Axogen, Inc.
AXGN · Electromedical and Electrotherapeutic Apparatus
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Tyndall Joseph A.: Form 4
Insider disclosure · Filed · Report period 02 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- AXGN · 05463X106 - Common Stock, $0.01 par value
Company details and SEC sources
CIK 0000805928 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AXGN on Nasdaq
- SEC industry group
- Electromedical and Electrotherapeutic Apparatus (Industrial Applications and Services)
- Business address
- 13631 Progress Blvd., Suite 400, Alachua, FL, 32615
- Incorporated in
- MN
- Fiscal year end
- 31 December
- Former names on EDGAR
- LECTEC CORP /MN/ (to 29 Sep 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields